NEW YORK--(BUSINESS WIRE)--Jul 10, 2019--
Medidata (NASDAQ: MDSO) today announced that it will release its second quarter 2019 results after the close of U.S. financial markets on Tuesday, July 23, 2019. Due to the company's pending acquisition by Dassault Systèmes, it will not host a conference call to discuss its results.
Medidata is leading the digital transformation of life science, with the world's most used platform for clinical development, commercial, and real-world data. Powered by artificial intelligence and delivered by top-ranked industry experts, Medidata helps pharmaceutical, biotech, medical device companies, and academic researchers accelerate value, minimize risk and optimize outcomes. Medidata and its companies, Acorn AI and SHYFT, serve 1,300 customers and partners worldwide and empower more than 150,000 certified users every day to create hope for millions of patients. Discover the future of life science: www.medidata.com
View source version on businesswire.com:https://www.businesswire.com/news/home/20190710005859/en/
Betsy Frank, 917-522-4620
Rosemarie Esposito, 646-362-3017
KEYWORD: UNITED STATES NORTH AMERICA NEW YORK
INDUSTRY KEYWORD: TECHNOLOGY MEDICAL DEVICES FINANCE PROFESSIONAL SERVICES BIOTECHNOLOGY HEALTH DATA MANAGEMENT
Copyright Business Wire 2019.
PUB: 07/10/2019 05:00 PM/DISC: 07/10/2019 05:00 PM